Table 2.
Effects of interfering ERK signaling-related genes/proteins on drug-induced behaviors
| Target genes/proteins | Behavioral effects | References |
|---|---|---|
| Ca2+-stimulated AC1/AC8 (KO) | ↑ acute cocaine-induced locomotion ↓ development of cocaine locomotor sensitization |
124 |
| Ras-GRF-1 (KO) | ↓ development and expression of cocaine locomotor sensitization ↓ cocaine-CPP ↓ repeated THC-induced behavioral tolerance |
127,199,200 |
| Ras-GRF-1 (OE) | ↑ development and expression of cocaine locomotor sensitization ↑ cocaine-CPP |
127 |
| Ras-GRF-2 (KO) | ↓ ethanol intake and preference (two bottle free choice task) | 242 |
| ERK1 (KO) | ↑ basal locomotor activity ↑ acute amphetamine-induced locomotion ↑ development of cocaine locomotor sensitization ↑ cocaine-CPP |
34,128,152,153 |
| ERK1 (KD in the PFC) | ↑ basal locomotor activity ↑ acute amphetamine-induced locomotion |
154 |
| ERK2 (OE in the VTA) | ↑ development and expression of cocaine locomotor sensitization ↑ cocaine-CPP |
130 |
| ERK2 (KD in the VTA) | ↓ development and expression of cocaine locomotor sensitization ↓ cocaine-CPP |
130 |
| MSK-1 (KO) | ↓ development and expression of cocaine locomotor sensitization ↑ cocaine-CPP |
79 |
| Inhibition of pElk-1 | ↓ development and expression of cocaine locomotor sensitization ↓ the establishment of cocaine-CPP |
74 |
KO = knockdown; KD = knockdown; OE = overexpression; ↑ = enhancing effect; ↓ = inhibiting effect